Vulvar Neoplasms, Benign and Malignant

Jill I. Allbritton

Research output: Contribution to journalReview article

Abstract

Cutaneous vulvar neoplasms are commonly encountered at gynecology visits, with 2% of women having a benign vulvar melanocytic nevus and 10% to 12% of nevi being vulvar. High-grade squamous intraepithelial lesions (vulvar intraepithelial neoplasia 2 or 3) occurs in 5 per 100,000 women, with increasing incidence in the past 30 years. The recognition of these lesions and differentiation between benign, premalignant, and malignant stages are crucial for adequate diagnosis, clinical monitoring, and treatment. The presentation, diagnosis, and management of benign and malignant vulvar proliferations are discussed with focus on practical aspects of clinical care.

Original languageEnglish (US)
Pages (from-to)339-352
Number of pages14
JournalObstetrics and Gynecology Clinics of North America
Volume44
Issue number3
DOIs
StatePublished - Sep 1 2017

Keywords

  • Basal cell carcinoma
  • Differentiated vulvar intraepithelial neoplasia (dVIN)
  • Genital nevi
  • High-grade squamous intraepithelial lesion (HSIL)
  • Melanosis
  • Paget disease
  • Squamous cell carcinoma (SCC)
  • Vulvar melanoma

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Vulvar Neoplasms, Benign and Malignant'. Together they form a unique fingerprint.

  • Cite this